SynthesisJournal of epidemiology and global health2026
Incidence and Predictors of Mortality Among Adults on Antiretroviral Therapy in Ethiopia: A Systematic Review and Meta-Analysis.
Synthesis in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the United Nations' plan to end Human Immunodeficiency Virus (HIV) as a public health concern by 2030, it remains a significant issue in low-income countries, including Ethiopia. Currently, there are no pooled estimates of mortality rate among adults on antiretroviral therapy in Ethiopia. This meta-analysis was conducted to fill this information gap, focusing on the incidence and predictors of mortality among adults receiving antiretroviral therapy in Ethiopia.
methodsThis systematic review followed the PRISMA guidelines, and relevant studies were obtained from the PubMed, CINAHL, Scopus, EMBASE, and Google Scholar databases. Data analysis for pooled estimates of incidence and predictors of mortality was conducted via STATA 17 software with the DerSimonian and Laird random-effects model. Heterogeneity was evaluated via Cochrane's Q-test and the I² statistic, and publication bias was assessed through funnel plots, Egger's test, and Trim-and-fill analysis.
resultsOf the 121,621 studies initially identified, only 31 met the rigorous inclusion criteria for the final meta-analysis, encompassing 24,504 participants in total. The pooled mortality rate among adults on antiretroviral therapy was 4 per 100 person-years (95% CI: 3-5, I² = 95.27%), based on 74,042.8 person-years of observation. Furthermore, advanced WHO clinical stage (pooled Adjusted Hazard Ratio(AHR) 1.68, 95% CI: 1.58-1.78), bedridden functional status (AHR 1.81, 95% CI: 1.67-1.95), anemia (AHR 1.89, 95% CI: 1.77-2.03), CD4 count below 50/mm³ (AHR 1.53, 95% CI: 1.42-1.65), fair or poor ART adherence (AHR 1.60, 95% CI: 1.45-1.75), and Tuberculosis co-infection (AHR 1.42, 95% CI: 1.32-1.53) were identified as predictors of mortality.
conclusionThe mortality rate observed in the current meta-analysis was clinically meaningful, indicating the need for strengthened efforts to reduce preventable deaths and achieve the 2030 targets. Moreover, advanced WHO clinical stage, bedridden functional status, anemia, CD4 count below 50/mm³, fair or poor ART adherence, and tuberculosis co-infection were identified as predictors of HIV-related mortality. This suggests that early HIV testing, timely initiation of treatment, and robust monitoring and evaluation of treatment should be prioritized to address the identified predictors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.